Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05297708 · ClinicalTrials.gov registry record

Office, Home, and Ambulatory Blood Pressure

A clinical trial of Elevated Blood Pressure, sponsored by Children's Hospital Medical Center, Cincinnati.

Active
Registry status
52
Enrollment target
1
Study location

NCT05297708: Active study of Elevated Blood Pressure, sponsored by Children's Hospital Medical Center, Cincinnati.

NCT05297708 is a study of Elevated Blood Pressure that is active but no longer recruiting, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 52 participants, below the 104-participant average among 6 other Elevated Blood Pressure trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05297708, a study of Elevated Blood Pressure, is active but no longer recruiting, sponsored by Children's Hospital Medical Center, Cincinnati.

ACTIVE NOT RECRUITING
Registry status
52 participants
Enrollment target
1
Study location

Study Summary

This will be a prospective observational study. The population would be pediatric patients 6 years to \<19 years of age who were referred for elevated blood pressure to investigate if home blood pressure (HBP) can determine blood pressure phenotype (normotensive, hypertensive, masked hypertension, white coat hypertension) as accurately as ambulatory blood pressure monitor (ABPM) in childhood and adolescence.

Primary Outcome

The primary objective of this study is to investigate if home blood pressure (HBP) can determine blood pressure phenotype (normotensive, hypertensive, masked hypertension, white coat hypertension) as accurately as ambulatory blood pressure monitor (ABPM) in childhood and adolescence.

Conditions Studied

Elevated Blood Pressure

Study Locations (1)

Ohio

  • Cincinnati Children's Hospital - Cincinnati

Trial Details

FieldValue
Enrollment Target 52 participants
Start Date 2022-03-24
Est. Completion 2026-09-01
Children's Hospital Medical Center, Cincinnati

571 total trials

What the registry record for NCT05297708 still lists

NCT05297708 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 104-participant average among 6 other Elevated Blood Pressure trials with a reported enrollment target (50% lower).

The record links to 1 condition, with Elevated Blood Pressure appearing as the primary indexed condition, and to 0 interventions.

NCT05297708 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT05297708 about?

NCT05297708 is a clinical study titled "Office, Home, and Ambulatory Blood Pressure". This will be a prospective observational study. The population would be pediatric patients 6 years to \<19 years of age who were referred for elevated blood pressure to investigate if home blood pressure (HBP) can determine blood pressure phenotype (normotensive, hypertensive, masked hypertension, w...

What is the current status of trial NCT05297708?

This trial is currently active not recruiting. The enrollment target is 52 participants. The study started on 2022-03-24. Estimated completion is 2026-09-01.

What conditions does trial NCT05297708 study?

This clinical trial studies the following conditions: Elevated Blood Pressure.

Who is sponsoring clinical trial NCT05297708?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05297708 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Elevated Blood Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02630121 · 52 participants · Phase 4

    Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea

  • NCT03629171 · 52 participants · Phase 2

    Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia

  • NCT04128748 · 52 participants · Phase 1

    Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome

  • NCT04150497 · 52 participants · Phase 1

    Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT05297708, the US trial registry maintained by the National Library of Medicine. NCT05297708 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.